Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luminus Biosciences is a contract research organization (CRO) that provides comprehensive preclinical drug discovery and development services to the biotechnology and pharmaceutical industries. Specializing in oncology, immunology, and inflammation, the company offers a wide range of in vitro and in vivo pharmacology services, including cell-based assays, flow cytometry, and animal model studies such as Cell Line-Derived Xenografts (CDX). Luminus Biosciences supports clients through various stages of research, from early-stage lead optimization to IND-enabling studies, utilizing their expertise in tumor biology to accelerate the development of novel therapeutics. Their service-oriented business model focuses on delivering high-quality data and technical support for complex biological evaluations. The company is headquartered in Rockville, Maryland, and serves a global client base in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luminus Biosciences.